GGTI 298

Catalog # Availability Size / Price Qty
2430/1
GGTI 298 | CAS No. 1217457-86-7 | Other Transferase Inhibitors
1 Image
Description: Geranylgeranyltransferase I (GGTase I) inhibitor

Chemical Name: N-[4-[2(R)-Amino-3-mercaptopropyl]amino-2-(1-naphthalenyl)benzoyl]-L-leucine methyl ester trifluoroacetate salt

Purity: ≥95%

Product Details
Citations (2)
Reviews

Biological Activity

GGTI 298 is a CAAZ peptidomimetic geranylgeranyltransferase I (GGTase I) inhibitor. Strongly inhibits the processing of geranylgeranylated Rap1A with little effect on processing of farnesylated Ha-Ras (IC50 values are 3 and > 10 μM respectively). Causes G0-G1 cell cycle block and apoptosis in A549 cells and inhibits cell invasion and migration in COLO 320CM cells.

Technical Data

M.Wt:
593.66
Formula:
C27H33N3O3S.CF3CO2H
Solubility:
Soluble to 25 mM in DMSO
Purity:
≥95%
Storage:
Store at -20°C
CAS No:
1217457-86-7

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.

Background References

  1. AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity

    Proc Natl Acad Sci USA, 2016;0(0):.
  2. Platelet-derived growth factor receptor tyrosine kinase phosphorylation requires protein geranylgeranylation but not farnesylation.
    McGuire et al.
    J.Biol.Chem., 1996;271:27402
  3. GGTI-298 induces G0-G1 block and apoptosis whereas FTI-227 causes G2-M enrichment in A549 cells.
    Miquel et al.
    Cancer Res., 1997;57:1846
  4. A yeast-based genomic strategy highlights the cell protein networks altered by FTase inhibitor peptidomimetics.
    Porcu et al.
    Mol.Cancer, 2010;9:197
  5. Selective inhibition of cancer cell invasion by a geranylgeranyltransferase inhibitor.
    Kusama et al.
    Clin.Exp.Meta., 2003;20:561

Product Datasheets

Or select another batch:
View Batch

Citations for GGTI 298

The citations listed below are publications that use Tocris products. Selected citations for GGTI 298 include:

2 Citations: Showing 1 - 2

  1. ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells.
    Authors: Luttman Et al.
    ABL allosteric inhibitors synergize with statins to  2021;37:109880
  2. Chenodeoxycholic Acid Requires Activation of EGFR, EPAC and Ca2+ to Stimulate CFTR-dependent Cl-Secretion in Human Colonic T84 Cells.
    Authors: Domingue Et al.
    American Journal of Physiology - Cell Physiology  2016;

FAQs

No product specific FAQs exist for this product, however you may

View all Small Molecule FAQs

Reviews for GGTI 298

There are currently no reviews for this product. Be the first to review GGTI 298 and earn rewards!

Have you used GGTI 298?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review
Tocris Bioscience is the leading supplier of novel and exclusive tools for life science research with over 30 years' experience in the industry. Tocris is a Bio-Techne brand.